Chemomab Therapeutics Ltd. American Depositary Share

CMMB · NASDAQ-CM

1.64

-0.52 (-24.07%)

Last price from Nasdaq, delayed

Valuation

Market value	11.88M
Price to book	1.2

Profitability (last 12 months)

Net income	-12.88M
Return on equity	-132.8%
Return on assets	-115.7%

Growth (last fiscal year, FY 2025)

EPS growth	-50.0%

Balance sheet (latest quarter)

Cash and equivalents	5.45M
Current ratio	7.42

Per share and dividends

Shares outstanding	575.38M
Dividends paid (last 12 months)	None

Trading

Price	1.64
52-week high	3.58
52-week low	1.35
1-year price change	-38.11%
Average volume (3 months)	166.8K
Beta against the S&P 500 (1 year)	1.75

Calculated from Chemomab Therapeutics Ltd. American Depositary Share's SEC filings (latest quarter ending Jun 30, 2025) and the price above. "Last 12 months" adds up the four most recent quarters. Beta compares one year of daily returns with the S&P 500 (SPY). Dividends from Polygon.io or Nasdaq.